Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112982 · ClinicalTrials.gov registry record · Phase 4
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
A Phase 4 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
NCT01112982 is a Phase 4 study that has completed, run by University of South Florida. The registered enrollment target is 74 participants.
The verdict
NCT01112982, a Phase 4 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to show that patients with gout suffer from chronic inflammation of their joints, observable by MRI, even in the absence of symptomatic gouty attacks. Secondary end-points of this study will include analyzing the effects of uric acid-lowering therapy (specifically with the FDA approved medication Febuxostat) in a subgroup of patients, checking for the presence of inflammatory markers to see if there is any correlation with the proposed chronic inflammation, and evaluating for other characteristic findings of gout on MRI.
Interventions
- DRUG Colchicine
- OTHER Magnetic Resonance Imaging
- DRUG Febuxostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112982
The ClinicalTrials.gov registry entry for NCT01112982 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Colchicine is the first listed.
NCT01112982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112982 about?
NCT01112982 is a clinical study titled "An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.". The purpose of this study is to show that patients with gout suffer from chronic inflammation of their joints, observable by MRI, even in the absence of symptomatic gouty attacks. Secondary end-points of this study will include analyzing the effects of uric acid-lowering therapy (specifically with t...
What is the current status of trial NCT01112982?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2010-05. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01112982?
The interventions under investigation include: Colchicine (DRUG), Magnetic Resonance Imaging (OTHER), Febuxostat (DRUG).
Who is sponsoring clinical trial NCT01112982?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.